Skip to search.
 FTSE 100 Up 0.07%
Streaming
Ticker Tape: On

TrovaGene, Inc. (TROV)

-NasdaqCM

6.85 20 May 21:00

Add to Portfolio
Prev Close:6.85
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:12.50
Beta:-1.09
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:2.09 - 8.96
Volume:0
Avg Vol (3m):72,363
Market Cap:106.28m
P/E (ttm):N/A
EPS (ttm):-0.81
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for TROV at this time.

Comparison

Symbol% ChgMkt Cap
TROV 0.00%106.28m
RHHBYN.MXUp 0.14%2.66t
SHP.LUp 0.19%11.53b
SUNPHARMA.NSUp 0.52%1.01t
GILD.MXUp 0.11%1.04t
» More Competitors

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):198.52
Ex-Dividend Date:N/A
» More Key Statistics

Analysts

Annual EPS Est (Dec-13) :-0.44
Quarterly EPS Est (Jun-13) :-0.10
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Trovagene Inc., a development stage molecular diagnostic company, focuses on the development and commercialization of proprietary diagnostic technologies for use in patient/disease screening and monitoring in various medical disciplines. more
Company Profile | Industry
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback